Brazil
23 articles related to "Brazil"
-
Chagas: Making a noise about the ‘silent disease’
14 April 2012 - The fight against Chagas – a tropical parasitic disease that affects between eight and ten million people in Latin America – has seen major advances in recent years. This...
Op-eds & Articles – Last updated 16 April 2012
www.msfaccess.org/content/chagas-making-noise-about-silent-disease -
Critical shortage of first-line therapy for Chagas: The story of benznidazole
In 2011, there were delays in rolling out screening and diagnosis activities in communities at risk in MSF projects in rural Bolivia and Paraguay due to the shortage of benznidazole. This was not just...
Web article – Last updated 10 April 2012
www.msfaccess.org/content/critical-shortage-first-line-therapy-chagas-story-benznidazole -
Argentina joins Brazil in producing life-saving drug for neglected disease
Second producer of drug used to treat Chagas welcomed, but more R&D is urgently needed Buenos Aires, 20 March 2012 - Medecins Sans Frontieres (MSF) has welcomed today’s announcement from...
Press Release – Last updated 16 April 2012
www.msfaccess.org/about-us/media-room/press-releases/argentina-joins-brazil-producing-life-saving-drug-neglected -
Brazilians demand greater access to crucial HIV drug
Civil society files patent opposition to increase access to HIV/AIDS medicines Rio de Janeiro, 10 November 2011 – Brazilian civil society will oppose a patent application today for the key...
Press Release – Last updated 11 November 2011
www.msfaccess.org/about-us/media-room/press-releases/brazilians-demand-greater-access-crucial-hiv-drug -
The shortage of benznidazole leaves thousands of Chagas patients without treatment
INTRODUCTION Médecins Sans Frontières (MSF) has been working on Chagas disease since 1999 in a number of Latin American countries, providing access to diagnosis and treatment to people...
Briefing – Last updated 05 October 2011
www.msfaccess.org/content/shortage-benznidazole-leaves-thousands-chagas-patients-without-treatment -
Treatment Ends for Chagas Patients
Treatment Shortage Forces MSF to Halt Diagnosing Chagas Disease in Paraguay; New Treatment Projects Suspended in Endemic Areas in Bolivia Bolivia 2011 © Vania Alves/MSF BARCELONA,...
Press Release – Last updated 10 April 2012
www.msfaccess.org/about-us/media-room/press-releases/treatment-ends-chagas-patients -
Untangling the Web of Antiretroviral Price Reductions: 14th Edition
The latest edition of Untangling the Web of Antiretroviral Price Reductions (UTW) released at the IAS 2011 in Rome demonstrates a growing and deadly divide in antiretroviral (ARV) prices offered to...
Report – Last updated 18 July 2011
www.msfaccess.org/content/untangling-web-antiretroviral-price-reductions-14th-edition -
Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries
Each year, MSF publishes a survey of the latest prices for antiretroviral medicines to treat people living with HIV/AIDS in developing countries. It started out as a way of offering a practical guide...
Web article – Last updated 08 August 2011
www.msfaccess.org/content/caught-middle-%E2%80%93-hiv-medicines-pricing-sky-high-%E2%80%98middle-income%E2%80%99-countries -
Pre-grant opposition victory in India
For the first time, a pre-grant opposition filed by Indian civil society for an antiretroviral (ARV) has led to a patent rejection. This sets an important precedent for the remaining 12 ARV oppositions...
Web article – Last updated 27 June 2008
www.msfaccess.org/content/pre-grant-opposition-victory-india -
Tenofovir and Valganciclovir Patent Oppositions
In a sign that civil society is turning up the heat in the struggle to access affordable medicines, two more oppositions to patents on AIDS drugs have been filed in India. Pre-grant opposition filed...
Web article – Last updated 18 January 2008
www.msfaccess.org/content/tenofovir-and-valganciclovir-patent-oppositions
